Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2000Breast Cancer ResearchOpen Access

The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer.

View Full Paper
Ask AI
Bookmark
Share

Authors

RCRoberto ChiarleBoston Children's Hospital
Michele Pagano
Michele PaganoFlorida State UniversityGIGiorgio InghiramiBoston University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chiarle et al. (2000) studied this question.

synapsesocial.com/papers/6a6558932130db5e95b2ee48https://doi.org/10.1186/bcr277
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p271995 · 1,839 citations
  2. 2High level expression of p27 kip1 and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27 kip1 and degree of malignancy in human breast and colorectal cancers1997 · 363 citations
  3. 3Cyclin-dependent kinase inhibitor p27Kipl expression and interaction with other cell cycle-associated proteins in mammary carcinoma1999 · 65 citations
  4. 4Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breast2000 · 34 citations